Viewing Study NCT07023432


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2026-01-01 @ 4:07 AM
Study NCT ID: NCT07023432
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-17
First Post: 2025-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module